Home > > > Report Detail

Post-pandemic Era - Global Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate

Publisher Name :
Date: 02-Aug-2022
No. of pages: 116

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch) released the «Post-pandemic Era-Global Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate», which aims to sort out the development status and trends of the Clinical Oncology Next Generation Sequencing (NGS) industry at home and abroad, estimate the overall market scale of the Clinical Oncology Next Generation Sequencing (NGS) industry and the market share of major countries, Clinical Oncology Next Generation Sequencing (NGS) industry, and study and judge the downstream market demand of Clinical Oncology Next Generation Sequencing (NGS) through systematic research, Analyze the competition pattern of Clinical Oncology Next Generation Sequencing (NGS), so as to help solve the pain points of various stakeholders in Clinical Oncology Next Generation Sequencing (NGS) industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018- 2028) of Clinical Oncology Next Generation Sequencing (NGS) Market by XYZResearch Include

- NorthAmerica

- Asia

- Europe

- Middle East & Africa

- South America

Competitive Analysis; Who are the Major Players in Clinical Oncology Next Generation Sequencing (NGS) Market?

- Illumina

- Roche

- Agilent Technologies

- Knome

- Genomatix Software

- GATC Biotech

- Oxford Nanopore Technologies

- Macrogen

- Life Technologies

- DNASTAR

- Exosome Diagnostics

- Biomatters

- CLC Bio

- BGI

- Qiagen

- Perkin Elmer

- Pacific Bioscience

- Partek

- GnuBIO

- Foundation Medicine

- Paradigm

- Caris Life Sciences

- Myriad Genetics

Major Type of Clinical Oncology Next Generation Sequencing (NGS) Covered in XYZResearch report:

- NGS Pre-Sequencing

- Sequencing

- NGS Data Analysis

- Primary, Secondary & Tertiary Data Analysis

Application Segments Covered in XYZResearch Market

- Academic & Clinical Research

- Hospitals & Clinics

- Pharma & Biotech Entities

For any other requirements, please feel free to contact us and we will provide you customized report.

Post-pandemic Era - Global Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate

Table of Contents

Post-pandemic Era-Global Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 NGS Pre-Sequencing -Product Introduction and Major Company
1.1.2 Sequencing -Product Introduction and Major Company
1.1.3 NGS Data Analysis -Product Introduction and Major Company
1.1.4 Primary, Secondary & Tertiary Data Analysis -Product Introduction and Major Company
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Five-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Sales (2018 & 2022 & 2026)
2.2 Regional Market Share in Terms of Revenue (2018 & 2022 & 2026)
2.3 Regional Market Share in Terms of Consumption (2018 & 2022 & 2026)
3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Assessment by Type
3.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Type (2018-2028)
3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Type (2018-2028)
3.3 North America Clinical Oncology Next Generation Sequencing (NGS) Sales and Revenue by Type (2018-2028)
3.4 Asia Clinical Oncology Next Generation Sequencing (NGS) Sales and Revenue by Type (2018-2028)
3.5 Europe Clinical Oncology Next Generation Sequencing (NGS) Sales and Revenue by Type (2018-2028)
3.6 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Sales and Revenue by Type (2018-2028)
3.7 South America Clinical Oncology Next Generation Sequencing (NGS) Sales and Revenue by Type (2018-2028)
4 Historical & Forecast Global Clinical Oncology Next Generation Sequencing (NGS) Market Assessment by Application
4.1 Global Clinical Oncology Next Generation Sequencing (NGS) Consumption and Consumption in Different Application Field (2018-2028)
4.2 North America Clinical Oncology Next Generation Sequencing (NGS) Consumption and Consumption in Different Application Field (2018-2028)
4.3 Asia Clinical Oncology Next Generation Sequencing (NGS) Consumption and Consumption in Different Application Field (2018-2028)
4.4 Europe Clinical Oncology Next Generation Sequencing (NGS) Consumption and Consumption in Different Application Field (2018-2028)
4.5 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Consumption and Consumption in Different Application Field (2018-2028)
4.6 South America Clinical Oncology Next Generation Sequencing (NGS) Consumption and Consumption in Different Application Field (2018-2028)
5 North America
5.1 US Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
5.2 Canada Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
5.3 Mexico Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
6 Asia
6.1 China Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
6.2 Japan Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
6.3 India Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
6.4 Korea Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
6.5 Southeat Asia Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
7 Europe
7.1 Germany Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
7.2 UK Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
7.3 France Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
7.4 Russia Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
7.5 Italy Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
8 Middle East and Africa
8.1 Saudi Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
8.2 UAE Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
8.3 Egypt Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
8.4 Nigeria Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
8.5 South Africa Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
9 South America
9.1 Brazil Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
9.2 Argentina Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
9.3 Colombia Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2018-2028)
10 Global Clinical Oncology Next Generation Sequencing (NGS) Average Price Trend
10.1 Market Price for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in North America (2018-2028)
10.2 Market Price for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in Asia (2018-2028)
10.3 Market Price for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in Europe (2018-2028)
10.4 Market Price for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in Middle East & Africa (2018-2028)
10.5 Market Price for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in South America (2018-2028)
11 Value Chain
11.1 Clinical Oncology Next Generation Sequencing (NGS) Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Clinical Oncology Next Generation Sequencing (NGS) Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.2.2 Post-pandemic Era
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors
12 Major Players of Global Clinical Oncology Next Generation Sequencing (NGS) Market, Competitive Analysis
12.1 Illumina
12.1.1 Illumina Company Profiles and Company News
12.1.2 Illumina Product Introduction
12.1.3 Illumina Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
12.1.4 SWOT Analysis
12.2 Roche
12.2.1 Roche Company Profiles and Company News
12.2.2 Roche Product Introduction
12.2.3 Roche Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
12.2.4 SWOT Analysis
12.3 Agilent Technologies
12.3.1 Agilent Technologies Company Profiles and Company News
12.3.2 Agilent Technologies Product Introduction
12.3.3 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
12.3.4 SWOT Analysis
12.4 Knome
12.4.1 Knome Company Profiles and Company News
12.4.2 Knome Product Introduction
12.4.3 Knome Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
12.4.4 SWOT Analysis
12.5 Life Technologies
12.5.1 Genomatix Software Company Profiles and Company News
12.5.2 Genomatix Software Product Introduction
12.5.3 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
12.5.4 SWOT Analysis
12.6 GATC Biotech
12.6.1 GATC Biotech Company Profiles and Company News
12.6.2 GATC Biotech Product Introduction
12.6.3 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
12.6.4 SWOT Analysis
12.7 Oxford Nanopore Technologies
12.7.1 Oxford Nanopore Technologies Company Profiles and Company News
12.7.2 Oxford Nanopore Technologies Product Introduction
12.7.3 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
12.7.4 SWOT Analysis
12.8 Macrogen
12.8.1 Macrogen Company Profiles and Company News
12.8.2 Macrogen Product Introduction
12.8.3 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
12.8.4 SWOT Analysis
12.9 Life Technologies
12.9.1 Life Technologies Company Profiles and Company News
12.9.2 Life Technologies Product Introduction
12.9.3 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
12.9.4 SWOT Analysis
12.10 DNASTAR
12.10.1 DNASTAR Company Profiles and Company News
12.10.2 DNASTAR Product Introduction
12.10.3 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
12.10.4 SWOT Analysis
12.11 Exosome Diagnostics
12.12 Biomatters
12.13 CLC Bio
12.14 BGI
12.15 Qiagen
12.16 Perkin Elmer
12.17 Pacific Bioscience
12.18 Partek
12.19 GnuBIO
12.20 Foundation Medicine
12.21 Paradigm
12.22 Caris Life Sciences
12.23 Myriad Genetics
13 Global Clinical Oncology Next Generation Sequencing (NGS) Market, Competitive Landscape and Market Forecast
13.1 Key Companies Dominating the Global Clinical Oncology Next Generation Sequencing (NGS) Market
13.2 Concentration Ratio (CR5) of Global Clinical Oncology Next Generation Sequencing (NGS) Market (2018)
13.2.1 Market Share of Top 5 Players in Term of Revenue (2018)
13.3 Concentration Ratio (CR5) of Global Clinical Oncology Next Generation Sequencing (NGS) Market (2022)
13.3.1 Market Share of Top 5 Players in Term of Revenue (2022)
14 Conclusion
15 Methodology and Data Source

List of Tables and Figures

Figure Product Introduction
Table Sales (K Units) and Revenue (Million USD) of Major Players (2018-2022)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Sales of Each Type (2018-2028)
Table Regional Market Share in Terms of Sales (2019-2026)
Figure Regional Market Share in Terms of Sales (2019 - 2020)
Table Regional Market Share in Terms of Revenue (2019-2026)
Figure Regional Market Share in Terms of Revenue (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit) by Type (2018-2028)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit) and Growth Rate (2018-2028)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share (%) by Type (2019 -2020)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Type (2018-2028)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2028)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share (%) by Type (2019-2020)
Figure North America Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit) by Type (2018-2028)
Figure North America Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit) and Growth Rate (2018-2028)
Figure North America Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Type (2018-2028)
Figure North America Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2028)
Figure Asia Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit) by Type (2018-2028)
Figure Asia Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit) and Growth Rate (2018-2028)
Figure Asia Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Type (2018-2028)
Figure Asia Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2028)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit) by Type (2018-2028)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit) and Growth Rate (2018-2028)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Type (2018-2028)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2028)
Figure Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit) by Type (2018-2028)
Figure Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit) and Growth Rate (2018-2028)
Figure Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Type (2018-2028)
Figure Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2028)
Figure South America Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit) by Type (2018-2028)
Figure South America Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit) and Growth Rate (2018-2028)
Figure South America Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Type (2018-2028)
Figure South America Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2028)
Table Historical & Forecast Clinical Oncology Next Generation Sequencing (NGS) Different Application Field Consumption (K Unit)
Figure Consumption (K Unit) and Growth Rate (2018-2028)
Figure Different Application Field Consumption Market Share (%) (2019-2020)
Table Historical & Forecast Clinical Oncology Next Generation Sequencing (NGS) Different Application Field Consumption (K Unit)
Figure North America Clinical Oncology Next Generation Sequencing (NGS) Consumption (K Unit) and Growth Rate (2018-2028)
Figure North America Clinical Oncology Next Generation Sequencing (NGS) Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Clinical Oncology Next Generation Sequencing (NGS) Different Application Field Consumption (K Unit)
Figure Asia Clinical Oncology Next Generation Sequencing (NGS) Consumption (K Unit) and Growth Rate (2018-2028)
Figure Asia Clinical Oncology Next Generation Sequencing (NGS) Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Clinical Oncology Next Generation Sequencing (NGS) Different Application Field Consumption (K Unit)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Consumption (K Unit) and Growth Rate (2018-2028)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Clinical Oncology Next Generation Sequencing (NGS) Different Application Field Consumption (K Unit)
Figure Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Consumption (K Unit) and Growth Rate (2018-2028)
Figure Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Clinical Oncology Next Generation Sequencing (NGS) Different Application Field Consumption (K Unit)
Figure South America Clinical Oncology Next Generation Sequencing (NGS) Consumption (K Unit) and Growth Rate (2018-2028)
Figure South America Clinical Oncology Next Generation Sequencing (NGS) Consumption Market Share (%) by Application (2018-2028)
Table Historical & Forecast Clinical Oncology Next Generation Sequencing (NGS) Different Application Field Consumption (K Unit)
Table US Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Canada Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Mexico Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table China Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Japan Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table India Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Korea Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Germany Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UK Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table France Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Russia Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Italy Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Saudi Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UAE Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Egypt Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Nigeria Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table South Africa Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Brazil Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Argentina Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Colombia Clinical Oncology Next Generation Sequencing (NGS) Capacity (K Units), Sales (K Units) and Consumption (K Units) (2018-2028) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Market Price (USD/Unit) for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in China
Table Market Price (USD/Unit) for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in EU
Table Market Price (USD/Unit) for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in USA
Table Market Price (USD/Unit) for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in Japan
Table Market Price (USD/Unit) for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in India
Table Market Price (USD/Unit) for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in Southeast Asia
Table Market Price (USD/Unit) for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in South America
Figure Value Chain Structure of Clinical Oncology Next Generation Sequencing (NGS)
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Clinical Oncology Next Generation Sequencing (NGS)
Figure Cost Structure of Clinical Oncology Next Generation Sequencing (NGS) in 2020
Table Distributors/Traders List
Table Illumina Profiles
Table Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure Illumina Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Illumina SWOT Analysis
Table Roche Profiles
Table Roche Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure Roche Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Roche SWOT Analysis
Table Agilent Technologies Profiles
Table Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Agilent Technologies SWOT Analysis
Table Knome Profiles
Table Knome Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure Knome Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Knome SWOT Analysis
Table Genomatix Software Profiles
Table Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure Genomatix Software Medical Devices & Consumables Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Genomatix Software SWOT Analysis
Table GATC Biotech Profiles
Table GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure GATC Biotech SWOT Analysis
Table Oxford Nanopore Technologies Profiles
Table Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Oxford Nanopore Technologies SWOT Analysis
Table Macrogen Profiles
Table Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure Macrogen Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Macrogen SWOT Analysis
Table Life Technologies Profiles
Table Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Life Technologies SWOT Analysis
Table DNASTAR Profiles
Table DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure DNASTAR SWOT Analysis
Table Exosome Diagnostics Profiles
Table Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Exosome Diagnostics SWOT Analysis
Table Biomatters Profiles
Table Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure Biomatters Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Biomatters SWOT Analysis
Table CLC Bio Profiles
Table CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure CLC Bio SWOT Analysis
Table BGI Profiles
Table BGI Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure BGI Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure BGI SWOT Analysis
Table Qiagen Profiles
Table Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure Qiagen Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Qiagen SWOT Analysis
Table Perkin Elmer Profiles
Table Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Perkin Elmer SWOT Analysis
Table Pacific Bioscience Profiles
Table Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Pacific Bioscience SWOT Analysis
Table Partek Profiles
Table Partek Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure Partek Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Partek SWOT Analysis
Table GnuBIO Profiles
Table GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure GnuBIO SWOT Analysis
Table Foundation Medicine Profiles
Table Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Foundation Medicine SWOT Analysis
Table Paradigm Profiles
Table Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure Paradigm Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Paradigm SWOT Analysis
Table Caris Life Sciences Profiles
Table Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Caris Life Sciences SWOT Analysis
Table Myriad Genetics Profiles
Table Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Figure Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Capacity (Unit), Sales (Unit), Revenue (Million USD) (2018-2022)
Figure Myriad Genetics SWOT Analysis

  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs